Title |
Intervention | NCT ID | Sponsor | Status |
|---|---|---|---|---|
| Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... | Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration | NCT02521285 | National Cancer Institute (NCI) | Active, not recruiting |
| Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma | Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration | NCT02965703 | National Cancer Institute (NCI) | Active, not recruiting |
| An Internet-based Program to Help Cancer Survivors Manage Pain | Internet-based pain coping skills program | NCT04462302 | Wake Forest University Health Sciences | Recruiting |
| Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... | Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery | NCT02598557 | National Cancer Institute (NCI) | Active, not recruiting |
| Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast | Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration | NCT03063619 | M.D. Anderson Cancer Center | Active, not recruiting |
| Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer... | Best Practice, Educational Intervention, Motivational Interviewing, Quality-of-Life Assessment, Questionnaire Administration, Text Message-based Navigation Intervention | NCT04379570 | Alliance for Clinical Trials in Oncology | Recruiting |
| Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts | Contrast-enhanced Magnetic Resonance Imaging, Digital Tomosynthesis Mammography, Quality-of-Life Assessment, Questionnaire Administration | NCT02933489 | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
Why I Joined a Clinical Trial
Hi, my name is Raffaellina and [am here] thanks to the European Institute of Oncology and to the research! I am 76 years old and I have been diagnosed [with] breast cancer. I have chosen to participate into a clinical trial because of the clear and accurate explanation of my options and future perspectives and for the confidence in research transmitted by the Team I felt as aā human beingā and not as a ānumberā, and this feeling has not changed afterwards. I was so scared about my future, but when the team proposed me to participate in the study, I have accepted it with enthusiasm. No adverse event occurred, and moreover, I have experienced benefit that impacted the definitive surgery. We need to trust and support clinical research!